Skip to main content
. 2021 Aug 14;2021:5294266. doi: 10.1155/2021/5294266

Table 2.

Biochemical parameters of HFD-treated groups.

Treated groups (14 months of age)
HFD SED HFD SED + MTF HFD SED + tBHQ HFD SED + MTF + tBHQ HFD + EX HFD + EX + MTF + tBHQ
AST (U/L) 49.4 ± 8.90 58.80 ± 18.83 66.60 ± 32.12 63.40 ± 22.63 54.6 ± 18.58 58.6 ± 24.24 
ALT (U/L) 15.20 ± 5.26 13.80 ± 4.49 13.80 ± 5.02 11.80 ± 3.03 10.6 ± 1.34 14.6 ± 7.40
GGT (U/L) 29.60 ± 16.47 17.80 ± 12.03 33.20 ± 36.26 13.00 ± 3.11 10.4 ± 0.89 24.2 ± 23.84
Cholesterol 60.2 ± 22.21 74.00 ± 9.30 78.20 ± 8.92 63.4 ± 11.33 63.0 ± 5.74 62.4 ± 12.68
HDL mg/dL 14.0 ± 6.51 15.00 ± 4.69 14.20 ± 5.26 14.20 ± 2.86 14.2 ± 1.28 13.6 ± 4.93
Tryglicerides mg/dL 45.45 ± 21.62 48.40 ± 28.89 69.80 ± 12.26 66 ± 30.46 49.6 ± 27.58  42.6 ± 16.56
Creatinine mg/dL 0.7 ± 0.31 0.32 ± 0.16 0.32 ± 0.21 0.48 ± 0.51 0.26 ± 0.08 0.36 ± 0.15
Glucose mg/dL 101.8 ± 7.82 95.20 ± 22.1 85.20 ± 18.16 106.6 ± 6.46 93.2 ± 13.72 106.2 ± 6.68

The table shows the mean and standard deviation of ALT, AST, GGT, cholesterol, HDL, triglycerides, creatinine, and glucose that were determined in HFD-rats and the respective treatments at 14 months of age. The significant statistical differences between groups with respect to the HFD are marked with . The exact probability value is indicated in the graph. The comparisons were established using ANOVA and a post hoc Holm-Sidak n = 5. p < 0.05.